HealthEquity, Inc. provided earnings guidance for the fiscal year ending January 31, 2023. For the year, the management expects revenues of $834 million to $844 million. Its outlook for net loss is between $43 million and $36 million, resulting in net loss of $0.51 to $0.43 per diluted share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
81.68 USD | +3.24% | +3.04% | +23.20% |
05-14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
05-14 | HealthEquity Completes Acquisition of Conduent's BenefitWallet | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.20% | 7.11B | |
+8.91% | 85.92B | |
+5.14% | 77.93B | |
-16.20% | 52.89B | |
+26.18% | 48.28B | |
+28.93% | 45.38B | |
-34.05% | 40.83B | |
+66.72% | 38.78B | |
-0.36% | 27.48B | |
-26.47% | 21.52B |
- Stock Market
- Equities
- HQY Stock
- News HealthEquity, Inc.
- HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023